Literature DB >> 20876052

Plasma glucose levels and white blood cell count are related with ankle brachial index in type 2 diabetic subjects.

Athanasia Papazafiropoulou1, Marina Kardara, Alexios Sotiropoulos, Stavros Bousboulas, Petroula Stamataki, Stavros Pappas.   

Abstract

INTRODUCTION: Type 2 diabetes mellitus (T2DM) is a major risk factor for peripheral arterial disease (PAD). A simple, noninvasive method for the estimation of PAD is ankle brachial index (ABI). The aim of the present study was to determine whether there is an association between ABI and cardiovascular risk factors in T2DM subjects without apparent macrovascular disease.
METHODS: A total of 125 T2DM subjects (84 males, 41 females, mean age ± standard deviation 62.2 ± 9.1 years) who had no apparent macrovascular disease and who attended the Health Center of Erymantheia between January 2008 and June 2009 were recruited to the study.
RESULTS: Of the study subjects 20% (n=25) had ABI <0.90. Univariate linear regression analysis showed that ABI was significantly associated with history of hypertension (p=0.02), fasting serum glucose levels (p=0.02), serum urea levels (p=0.005), serum uric acid levels (p=0.007) and white blood cell (WBC) count (p=0.04). Multivariate linear regression analysis demonstrated significant independent associations between ABI and fasting serum glucose levels (p=0.03) as well as WBC count (p=0.03).
CONCLUSIONS: Elevated plasma glucose and WBC count increase the risk of PAD in asymptomatic diabetics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876052

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666


  2 in total

1.  Peripheral arterial disease of the lower extremities.

Authors:  Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

2.  Correlation between peripheral white blood cell counts and hyperglycemic emergencies.

Authors:  Wei Xu; Hai-feng Wu; Shao-gang Ma; Feng Bai; Wen Hu; Yue Jin; Hong Liu
Journal:  Int J Med Sci       Date:  2013-04-18       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.